A ‘silent’ COVID surge may hit the US in early 2025, experts warn — here's what that means
They're calling it "silent" because the wave follows a long period of unusually low COVID activity this fall, so many people ...
COVID-19 Turns 5: Looking Back And Looking Forward
The world first became aware of Covid-19 five years ago. We evaluate where we are, remember how we got here, and consider ...
Long COVID Breakthrough: Spike Proteins Persist in Brain for Years
Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...
Paxlovid may help some long COVID patients: Research
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long COVID when administered outside of an infection. Administration of Paxlovid ...
What Will Happen to COVID-19 in 2025? Experts Explain
Another year has gone by since the 2020 pandemic and COVID-19 remains at large, so experts weigh in on what will change in 2025.
5 things we know and still don't know about COVID, 5 years after it appeared
It can take several weeks to bounce back after a bout of COVID-19, but some people develop more persistent problems. The ...
Too Old to Operate1d
SARS-CoV-2 Surveillance in Homeless Shelters Using Self-Collected Swabs
The following is a summary of “Four COVID-19 screening strategies for early case identification within the homeless shelter ...
New Scientist5d
The big unanswered questions about the covid-19 coronavirus
Despite studying the SARS-CoV-2 virus for five years, scientists still have questions, from the extent to which it can ...
Could it be COVID? Here are the symptoms to watch out for in 2024
COVID symptoms can be mild, severe, or nonexistent, according to the CDC—and can appear as late as two weeks after you’ve ...
Cellular interactions help explain vascular complications due to COVID-19 virus infection
COVID-19 is a respiratory disease primarily affecting the lungs. However, the SARS-CoV-2 virus that causes COVID-19 surprised ...
Medindia1d
Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System
Nuclein, a leader in rapid, point-of-care molecular diagnostics, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement ...